ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
3177Followers
0Topic
0Badge
ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 214,130 shares, the number of shares held increased 2.74% compared to the previous period and now represents 1.22% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 302,956 shares, the number of shares held increased 2.74% compared to the previous period and now represents 1.1% of the total position.
ARKG Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 60,927 shares, the number of shares held increased 2.74% compared to the previous period and now represents 5.58% of the total position.
ARKG Investment Tracker position change: Increased position in Kymera Therapeutics, Inc. by 2,783 shares, the number of shares held increased 2.74% compared to the previous period and now represents 0.54% of the total position.
ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 24,150 shares, the number of shares held increased 2.74% compared to the previous period and now represents 1.88% of the total position.
ARKG Investment Tracker position change: Increased position in Freenome, Inc. by 142,283 shares, the number of shares held increased 12.1% compared to the previous period and now represents 0.78% of the total position.
ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 50,577 shares, the number of shares held increased 2.74% compared to the previous period and now represents 2.36% of the total position.
ARKG Investment Tracker position change: Increased position in CareDx by 23,991 shares, the number of shares held increased 2% compared to the previous period and now represents 3.85% of the total position.
ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 30,935 shares, the number of shares held increased 2.74% compared to the previous period and now represents 1.43% of the total position.
ARKG Investment Tracker position change: Decreased position in Personalis by 600,773 shares, the number of shares held decreased 17.87% compared to the previous period and now represents 2.14% of the total position.
ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 135,286 shares, the number of shares held increased 2.74% compared to the previous period and now represents 2.78% of the total position.
ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 43,539 shares, the number of shares held increased 2.74% compared to the previous period and now represents 0.99% of the total position.
ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 14,260 shares, the number of shares held increased 2.74% compared to the previous period and now represents 1.79% of the total position.
ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 135,953 shares, the number of shares held increased 2.74% compared to the previous period and now represents 1.88% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 408,089 shares, the number of shares held increased 2.74% compared to the previous period and now represents 2.78% of the total position.
ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 62,307 shares, the number of shares held increased 2.74% compared to the previous period and now represents 2.69% of the total position.
ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 62,215 shares, the number of shares held increased 2.74% compared to the previous period and now represents 2.84% of the total position.
ARKG Investment Tracker position change: Increased position in Absci Corporation. by 293,204 shares, the number of shares held increased 2.74% compared to the previous period and now represents 4.67% of the total position.
ARKG Investment Tracker position change: Increased position in Veracyte by 43,033 shares, the number of shares held increased 2.74% compared to the previous period and now represents 3.42% of the total position.
ARKG Investment Tracker position change: Increased position in Illumina by 10,235 shares, the number of shares held increased 2.74% compared to the previous period and now represents 5.08% of the total position.
Go to Tiger App to see more news